- Home
- CCU vs ELVN Comparison
CCU vs ELVN Comparison
Compare CCU & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CCU | ELVN |
|---|---|---|
| Founded | 1850 | 2016 |
| Country | Chile | United States |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.6B |
| IPO Year | 2001 | 2020 |
Fundamental Metrics
Financial Performance| Metric | CCU | ELVN |
|---|---|---|
| Price | $11.19 | $35.71 |
| Analyst Decision | Strong Sell | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $12.00 | ★ $43.40 |
| AVG Volume (30 Days) | 159.7K | ★ 646.0K |
| Earning Date | 05-06-2026 | 05-11-2026 |
| Dividend Yield | ★ 1.90% | N/A |
| EPS Growth | N/A | ★ 3.17 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $7.42 | N/A |
| Revenue Next Year | $4.71 | N/A |
| P/E Ratio | $18.35 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.71 | $14.79 |
| 52 Week High | $15.36 | $48.53 |
Technical Indicators
Market Signals| Indicator | CCU | ELVN |
|---|---|---|
| Relative Strength Index (RSI) | 41.12 | 34.23 |
| Support Level | $10.81 | $19.19 |
| Resistance Level | $12.37 | $40.62 |
| Average True Range (ATR) | 0.39 | 1.94 |
| MACD | -0.03 | -0.76 |
| Stochastic Oscillator | 5.85 | 8.82 |
Price Performance
Historical ComparisonAbout CCU Compania Cervecerias Unidas S.A.
United Breweries Co Inc is a multi-category beverage company with operations in Chile, Argentina, Bolivia, Colombia, Paraguay and Uruguay. The company is a player in each one of the beverage categories in which it participates in Chile, including beer, soft drinks, mineral and bottled water, juice, wine, cider and pisco, among others. The Company has three operating segment with respect to its revenues in the geographic areas of commercial activity: Chile; International business and Wine. It generates maximum revenue from Chile.
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.